Patrick J Crutcher
CIK 1754540 · VP, Business Development · last filed 2026-07-20
Patrick J Crutcher is a VP, Business Development who has filed 4 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for JSPR, was dated Jul 20, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| JSPR | Director | — | $0.69 | — | $0 | 1 | 2026-07-20 |
| Avalo Therapeutics, Inc. (CERC) Delisted | VP, Business Development | 1,634,771 | $2.93 | $4.79M | $0 | 1 | 2019-04-02 |
| Avalo Therapeutics, Inc. (CERCW) Delisted | VP, Business Development | 1,641,642 | — | — | $0 | 2 | 2018-10-04 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-20 | JSPR | Mixed | — | $0 | EDGAR |
| 2019-04-02 | Avalo Therapeutics, Inc. (CERC) Delisted | Mixed | −6,871 | $0 | EDGAR |
| 2018-10-04 | Avalo Therapeutics, Inc. (CERCW) Delisted | Grant (A) | +1,641,642 | $0 | EDGAR |
| 2018-09-27 | Avalo Therapeutics, Inc. (CERCW) Delisted | Grant (A) | +1,645,286 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.